¥8.75 ($1.30)

+0.20 (+2.34%)

SHZ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 39 · ¥7.4B mcap · 639M float · 3.94% daily turnover

Revenue

$2.2B -6.9% ▼

5Y CAGR: -9.1%

Gross Profit

$1.3B -9.6% ▼

5Y CAGR: -10.2%

Operating Income

$247M -1.6% ▼

5Y CAGR: -6.8%

Net Income

$223M +3.0% ▲

5Y CAGR: -4.0%

EPS (Diluted)

$0.26 +4.0% ▲

5Y CAGR: -4.3%

EBITDA

$374M +1.8% ▲

5Y CAGR: -6.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.8B	$3.0B	$3.0B	$2.4B	$2.2B
YoY Growth	+6.3%	-19.8%	-2.4%	-19.9%	-6.9%
Cost of Revenue	$1.6B	$1.3B	$1.2B	$985M	$954M
Gross Profit	$2.2B	$1.8B	$1.8B	$1.4B	$1.3B
Gross Margin	58.8%	58.5%	60.3%	58.5%	56.8%
R&D Expenses	$118M	$142M	$145M	$146M	$131M
SG&A Expenses	$1.7B	$1.4B	$1.3B	$1.0B	$858M
Operating Expenses	$1.9B	$1.3B	$1.4B	$1.1B	$1.0B
Operating Income	$366M	$454M	$350M	$251M	$247M
Operating Margin	9.7%	15.0%	11.8%	10.6%	11.2%
Interest Expense	$9M	$5M	$4M	$3M	$2M
Income Before Tax	$357M	$455M	$351M	$253M	$308M
Tax Expense	$89M	$100M	$55M	$37M	$48M
Net Income	$271M	$358M	$297M	$216M	$223M
Net Margin	7.2%	11.8%	10.0%	9.1%	10.1%
EPS (Diluted)	$0.32	$0.42	$0.35	$0.25	$0.26
EBITDA	$493M	$353M	$401M	$280M	$374M
Shares Outstanding	855M	856M	856M	850M	846M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$384M	$308M	$806M	$459M	$363M	$602M	$973M	$659M
Cost of Revenue	$148M	$140M	$322M	$193M	$139M	$254M	$384M	$291M
Gross Profit	$236M	$168M	$484M	$265M	$224M	$348M	$590M	$368M
Gross Margin	61.4%	54.7%	60.0%	57.9%	61.7%	57.8%	60.6%	55.9%
R&D Expenses	$32M	$49M	$24M	$38M	$32M	$47M	$25M	$32M
SG&A Expenses	$176M	$162M	$305M	$194M	$187M	$208M	$320M	$195M
Operating Expenses	$192M	$204M	$334M	$229M	$202M	$266M	$349M	$239M
Operating Income	$44M	-$35M	$150M	$37M	$22M	$82M	$240M	$129M
Operating Margin	11.5%	-11.5%	18.6%	8.0%	6.0%	13.7%	24.7%	19.6%
Interest Expense	$641K	$492K	$1M	$0	$426K	$287K	$364K	$530K
Income Before Tax	$44M	-$35M	$150M	$37M	$22M	$98M	$240M	$148M
Tax Expense	$9M	-$11M	$29M	$5M	$9M	$5M	$40M	$20M
Net Income	$36M	-$24M	$117M	$27M	$8M	$71M	$165M	$85M
Net Margin	9.3%	-7.8%	14.5%	5.9%	2.1%	11.8%	16.9%	12.9%
EPS (Diluted)	$0.04	$-0.03	$0.14	$0.03	$0.01	$0.08	$0.19	$0.10
EBITDA	$75M	-$46M	$171M	$50M	$50M	$130M	$241M	$163M
Shares Outstanding	847M	847M	846M	846M	846M	846M	846M	846M

000989.SZ SHZ